Advertisement
Screener

FORTE BIOSCIENCES, INC. (FBRX) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value

2.8 / 5 stars · 68/120 Roast Me

FORTE BIOSCIENCES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value

FORTE BIOSCIENCES, INC. (FBRX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $48.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.

Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2026-08-12

  • FORTE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2026-06-30 was $48.00K.
  • FORTE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2025-12-31 was $6.00K.
  • FORTE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2025-09-30 was $6.00K.
  • FORTE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
  • FORTE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2025 was $12.00K.
  • FORTE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2024 was $0.00.
  • FORTE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2021 was $366.00K, a 44.09% increase from fiscal 2020.
  • FORTE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2020 was $254.00K, a 48.27% decline from fiscal 2019.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month
2026-06-30$48.00K
10-Q · filed 2026-08-12
$48.00K
10-Q · filed 2026-08-12
2025-12-31$6.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
$12.00K
derived: sum of 2 quarters · filed 2026-03-31
$12.00K
10-K · filed 2026-03-31
2025-09-30$6.00K
10-Q · filed 2025-11-14
$6.00K
10-Q · filed 2025-11-14
2024-12-31$0.00
10-K · filed 2026-03-31
2021-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31
$84.00K
derived: sum of 2 quarters · filed 2022-03-31
$146.00K
derived: sum of 3 quarters · filed 2022-03-31
$366.00K
10-K · filed 2022-03-31
2021-09-30$84.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08
$146.00K
derived: sum of 2 quarters · filed 2021-11-08
$366.00K
10-Q · filed 2021-11-08
$371.00K
derived: sum of 4 quarters · filed 2021-11-08
2021-06-30$62.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16
$282.00K
10-Q · filed 2021-08-16
$287.00K
derived: sum of 3 quarters · filed 2021-08-16
2021-03-31$220.00K
10-Q · filed 2021-05-10
$225.00K
derived: sum of 2 quarters · filed 2021-05-10
2020-12-31$5.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16
$254.00K
10-K · filed 2021-03-16
2020-09-30$249.00K
10-Q · filed 2020-11-09
2019-12-31$491.00K
10-K · filed 2020-02-27
2018-12-31$508.00K
10-K · filed 2020-02-27
2017-12-31$677.00K
10-K · filed 2020-02-27
2017-03-31$300.00K
10-Q · filed 2017-05-23
2016-12-31$62.00K
10-K · filed 2019-02-27
2016-03-31$9.00K
10-Q · filed 2017-05-23
2015-12-31$160.00K
10-K · filed 2018-03-09